Skip to main content
Figure 5 | BMC Cancer

Figure 5

From: The synthetic peptide P111-136 derived from the C-terminal domain of heparin affin regulatory peptide inhibits tumour growth of prostate cancer PC-3 cells

Figure 5

Inhibition of HARP-induced in vivo angiogenesis by peptide P111-136. Liquid Matrigel™ at 4°C was injected subcutaneously into Swiss mice. The Matrigel™ was used alone or after incorporation of HARP, P111-136, or both. The animals were sacrificed 8 days later; the Matrigel™ plugs were removed, sectioned, stained using the Gomori-Trichrome method, and examined under the microscope. Scale bar, 100 μm. Micrographs of Gomori-Trichrome stained Matrigel™ plug (A) alone, (B) containing 1 μM of P111-136, (C), containing 5 nM of HARP, or (D) containing 5 nM of HARP and 1 μM of P111-136. (E) endothelial-cell migration into the Matrigel™ was quantified as the mean cell count in six fields in each of three Matrigel™ plug sections per mouse, data are means +/- SD of values in four mice per group. **p < 0.01.

Back to article page